Invesco NASDAQ Future Gen 200 ETF (QQQS)
| Assets | $9.89M |
| Expense Ratio | 0.20% |
| PE Ratio | n/a |
| Shares Out | 300,001 |
| Dividend (ttm) | $0.60 |
| Dividend Yield | 1.83% |
| Ex-Dividend Date | Sep 22, 2025 |
| Payout Ratio | n/a |
| 1-Year Return | +25.81% |
| Volume | 6,930 |
| Open | 32.82 |
| Previous Close | 32.51 |
| Day's Range | 32.45 - 32.89 |
| 52-Week Low | 19.55 |
| 52-Week High | 33.30 |
| Beta | 1.51 |
| Holdings | 205 |
| Inception Date | Oct 13, 2022 |
About QQQS
Fund Home PageThe Invesco NASDAQ Future Gen 200 ETF (QQQS) is an exchange-traded fund that is based on the Nasdaq Innovators Completion Cap index. The fund tracks an equal-weighted index of 200 NASDAQ-listed stocks selected based on the value of their patent portfolios. The portfolio excludes the largest 200 stocks listed on NASDAQ. QQQS was launched on Oct 13, 2022 and is issued by Invesco.
Top 10 Holdings
8.48% of assets| Name | Symbol | Weight |
|---|---|---|
| uniQure N.V. | QURE | 1.49% |
| Short-Term Investment Trust - Invesco Government & Agency Portfolio | AGPXX | 1.21% |
| ClearPoint Neuro, Inc. | CLPT | 0.88% |
| Nektar Therapeutics | NKTR | 0.87% |
| Ocugen, Inc. | OCGN | 0.69% |
| Ionis Pharmaceuticals, Inc. | IONS | 0.69% |
| Ballard Power Systems Inc. | BLDP | 0.68% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 0.67% |
| Aquestive Therapeutics, Inc. | AQST | 0.65% |
| CytomX Therapeutics, Inc. | CTMX | 0.65% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2025 | $0.39927 | Sep 26, 2025 |
| Jun 23, 2025 | $0.0917 | Jun 27, 2025 |
| Mar 24, 2025 | $0.06147 | Mar 28, 2025 |
| Dec 23, 2024 | $0.04816 | Dec 27, 2024 |
| Sep 23, 2024 | $0.11363 | Sep 27, 2024 |
| Mar 18, 2024 | $0.06716 | Mar 22, 2024 |
News
Fed Help Could Be on the Way for This ETF
One day doesn't make a trend. But it's hard to ignore the effect Fed Chair Powell's comments made last Friday had on equities, particularly small-caps.
Keep It Simple With Small-Caps
Small-cap stocks and ETFs appear to be finding solid footing. That's an arguably surprising scenario given the reputation of summer months being trying for equities.
How To Avoid The Worst Style ETFs For Q1 2025
ETF issuance is profitable for Wall Street, leading to an overwhelming number of ETFs that may not serve investors' best interests. Avoid ETFs with less than $100 million in assets due to inadequate l...
Invesco takes the regulatory steps to expand its ETF business in Japan
ATLANTA , June 20, 2023 /PRNewswire/ -- Invesco Capital Management LLC, an investment adviser managing an extensive family of exchange-traded funds (ETFs), announced today that our global ETF business...